NCT03306199已完成不适用
Turbo Power Laser Atherectomy Combined With Drug Coated Balloon Angioplasty for the Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Spectranetics Corporation1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2017年10月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 82
- 试验地点
- 1
- 主要终点
- Number of Participants Free From Target Lesion Revascularization (TLR)
研究概览
简要总结
A retrospective study to evaluate Turbo Power laser atherectomy + drug coated balloon (DCB) angioplasty for the treatment of femoropopliteal de novo/restenotic lesions and in-stent restenosis (ISR).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients treated for femoropopliteal de novo/restenotic lesions or in-stent restenosis using Turbo Power laser atherectomy plus drug coated balloon angioplasty
排除标准
- •Any incomplete data on procedural approach and treatment
结局指标
主要结局
Number of Participants Free From Target Lesion Revascularization (TLR)
时间窗: 1 year
A Target Lesion Revascularization is defined as any percutaneous or surgical intervention to treat a restenosis or reocclusion in the target lesion
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions.Critical Limb IschemiaInfrapopliteal LesionsNCT04365075Xuanwu Hospital, Beijing184
Approved For Marketing
不适用
Athrectomy and Drug Eluting Balloon Therapy (ADEBT) on the Femoral Popliteal ArteriesPeripheral Arterial DiseaseNCT02686541Changi General Hospital
已完成
2 期
Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent RestenosisPeripheral Arterial DiseaseNCT01330628Spectranetics Corporation252
已完成
不适用
A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular BlockagesPeripheral Arterial DiseaseNCT04241224Ra Medical Systems108
已完成
2 期
Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or CarboplatinUnresectable Intrahepatic CholangiocarcinomaNCT01648023Robert C. Martin49